FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895577486> ?p ?o ?g. }

• W2895577486 endingPage "581" @default.
• W2895577486 startingPage "572" @default.
• W2895577486 abstract "Obstructive sleep apnea (OSA) is associated with cancer incidence and mortality. The underlying mechanism is unclear. This study aims to evaluate the influence of intermittent hypoxia (IH), a novel hallmark of OSA, on tumor and to access the anti-tumor effect of endostatin on a mouse model with OSA.The C57BL/6 J mice were randomly classified into four groups: control (normoxia) (CTL), control plus endostatin (CTL + ED), IH, and IH plus endostatin (IH + ED). Mice in IH and IH + ED groups were subjected to IH 8 h per day in 5 weeks. Lewis lung cancer cells were injected into the flank of each mouse after 1 week of IH exposure. Endostatin was also intraperitoneally injected after tumor volume reached about 200 mm3. The maximum standard uptake values (SUVmax) were detected by micro-positron emission tomography-computed tomography (micro-PET-CT) imaging prior and post-endostatin administration. Microvessel density (MVD) and vascular endothelial growth factor (VEGF) were determined for evaluating the anti-tumor effect of endostatin among the normoxia and IH conditions.Mice had higher SUVmax in the IH group than the CTL group (p < 0.01). When compared with mice in the CTL group, those in the IH group had significantly greater MVD values (p < 0.001). The SUVmax can be attenuated by endostatin both in the CTL (p < 0.01) and IH conditions (p < 0.001). When compared with CTL group, mice in the IH group had increased MVD values (p < 0.001) and VEGF expression both at mRNA (p < 0.05) and protein levels (p < 0.001 in western blotting results). Treatment with endostatin attenuated serum and tissue VEGF levels, lowering the MVD values. As compared to normoxia condition, the endostatin-therapeutic effects were more significant under the IH condition (p < 0.05 in western blotting results).Micro-PET-CT imaging is a promising non-invasive technique to evaluate the tumor metabolic characteristics under IH condition in vivo. The anti-tumor effect of endostatin under IH condition is superior to that of the normoxia condition." @default.
• W2895577486 created "2018-10-12" @default.
• W2895577486 creator A5004901241 @default.
• W2895577486 creator A5008001964 @default.
• W2895577486 creator A5015446580 @default.
• W2895577486 creator A5016477165 @default.
• W2895577486 creator A5023905225 @default.
• W2895577486 creator A5033508513 @default.
• W2895577486 creator A5033961432 @default.
• W2895577486 creator A5038165954 @default.
• W2895577486 creator A5067265615 @default.
• W2895577486 creator A5089490201 @default.
• W2895577486 creator A5090335964 @default.
• W2895577486 date "2018-10-06" @default.
• W2895577486 modified "2023-10-05" @default.
• W2895577486 title "Anti-tumor effect of endostatin in a sleep-apnea mouse model with tumor" @default.
• W2895577486 cites W1788205751 @default.
• W2895577486 cites W2015511926 @default.
• W2895577486 cites W2021293735 @default.
• W2895577486 cites W2023073108 @default.
• W2895577486 cites W2032617616 @default.
• W2895577486 cites W2033094833 @default.
• W2895577486 cites W2042958005 @default.
• W2895577486 cites W2052874463 @default.
• W2895577486 cites W2075780259 @default.
• W2895577486 cites W2084009434 @default.
• W2895577486 cites W2094828940 @default.
• W2895577486 cites W2096719319 @default.
• W2895577486 cites W2108281717 @default.
• W2895577486 cites W2120712387 @default.
• W2895577486 cites W2122150741 @default.
• W2895577486 cites W2126868294 @default.
• W2895577486 cites W2131798870 @default.
• W2895577486 cites W2132522015 @default.
• W2895577486 cites W2133396341 @default.
• W2895577486 cites W2142037875 @default.
• W2895577486 cites W2149638664 @default.
• W2895577486 cites W2176841932 @default.
• W2895577486 cites W2319962899 @default.
• W2895577486 cites W2411753449 @default.
• W2895577486 cites W2470984080 @default.
• W2895577486 cites W2528213963 @default.
• W2895577486 cites W2545338794 @default.
• W2895577486 cites W2589751926 @default.
• W2895577486 cites W2624456170 @default.
• W2895577486 cites W2725436349 @default.
• W2895577486 cites W2747982402 @default.
• W2895577486 cites W2766696823 @default.
• W2895577486 cites W2791698777 @default.
• W2895577486 cites W2792901908 @default.
• W2895577486 cites W2802893198 @default.
• W2895577486 cites W2805748153 @default.
• W2895577486 doi "https://doi.org/10.1007/s12094-018-1955-8" @default.
• W2895577486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30293229" @default.
• W2895577486 hasPublicationYear "2018" @default.
• W2895577486 type Work @default.
• W2895577486 sameAs 2895577486 @default.
• W2895577486 citedByCount "13" @default.
• W2895577486 countsByYear W28955774862019 @default.
• W2895577486 countsByYear W28955774862020 @default.
• W2895577486 countsByYear W28955774862021 @default.
• W2895577486 countsByYear W28955774862022 @default.
• W2895577486 countsByYear W28955774862023 @default.
• W2895577486 crossrefType "journal-article" @default.
• W2895577486 hasAuthorship W2895577486A5004901241 @default.
• W2895577486 hasAuthorship W2895577486A5008001964 @default.
• W2895577486 hasAuthorship W2895577486A5015446580 @default.
• W2895577486 hasAuthorship W2895577486A5016477165 @default.
• W2895577486 hasAuthorship W2895577486A5023905225 @default.
• W2895577486 hasAuthorship W2895577486A5033508513 @default.
• W2895577486 hasAuthorship W2895577486A5033961432 @default.
• W2895577486 hasAuthorship W2895577486A5038165954 @default.
• W2895577486 hasAuthorship W2895577486A5067265615 @default.
• W2895577486 hasAuthorship W2895577486A5089490201 @default.
• W2895577486 hasAuthorship W2895577486A5090335964 @default.
• W2895577486 hasBestOaLocation W28955774861 @default.
• W2895577486 hasConcept C126322002 @default.
• W2895577486 hasConcept C142724271 @default.
• W2895577486 hasConcept C147969180 @default.
• W2895577486 hasConcept C167672396 @default.
• W2895577486 hasConcept C167734588 @default.
• W2895577486 hasConcept C203014093 @default.
• W2895577486 hasConcept C2776006263 @default.
• W2895577486 hasConcept C2776256026 @default.
• W2895577486 hasConcept C2777025900 @default.
• W2895577486 hasConcept C2780394083 @default.
• W2895577486 hasConcept C2781326671 @default.
• W2895577486 hasConcept C71924100 @default.
• W2895577486 hasConcept C75920679 @default.
• W2895577486 hasConcept C8891405 @default.
• W2895577486 hasConceptScore W2895577486C126322002 @default.
• W2895577486 hasConceptScore W2895577486C142724271 @default.
• W2895577486 hasConceptScore W2895577486C147969180 @default.
• W2895577486 hasConceptScore W2895577486C167672396 @default.
• W2895577486 hasConceptScore W2895577486C167734588 @default.
• W2895577486 hasConceptScore W2895577486C203014093 @default.
• W2895577486 hasConceptScore W2895577486C2776006263 @default.
• W2895577486 hasConceptScore W2895577486C2776256026 @default.

• next